2.Naghavi, M et al. (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet 390, 1151–1210.
4.Yu, L et al. (2014) Application of a new hybrid model with seasonal auto-regressive integrated moving average (ARIMA) and nonlinear auto-regressive neural network (NARNN) in forecasting incidence cases of HFMD in Shenzhen, China. PLoS ONE 9, e98241.
5.Wang, T et al. (2016) Using an autoregressive integrated moving average model to predict the incidence of hemorrhagic fever with renal syndrome in Zibo, China, 2004–2014. Japanese Journal of Infectious Diseases 69, 279–284.
6.Papenburg, J et al. (2016) The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza. Epidemiology and Infection 144, 1592–1600.
7.Liu, L et al. (2016) Predicting the incidence of hand, foot and mouth disease in Sichuan province, China using the ARIMA model. Epidemiology and Infection 144, 144–151.
8.Zhang, ZB et al. (2016) Seasonal variation and related influencing factors for tuberculosis. Zhonghua Liu Xing Bing Xue Za Zhi 37, 1183–1186.
9.Wang, KW et al. (2017) Hybrid methodology for tuberculosis incidence time-series forecasting based on ARIMA and a NAR neural network. Epidemiology and Infection 145, 1118–1129.
10.Korthals Altes, H et al. (2012) Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency? International Journal of Tuberculosis and Lung Disease 16, 639–644.
11.Wah, W et al. (2014) Time series analysis of demographic and temporal trends of tuberculosis in Singapore. BMC Public Health 14, 1121.
12.Bras, AL et al. (2014) Trends, seasonality and forecasts of pulmonary tuberculosis in Portugal. International Journal of Tuberculosis and Lung Disease 18, 1202–1210.
13.Box, GE et al. (1976) Time Series Analysis: Forecasting and Control. Editors. Oakland: Holden-Day, pp. 300–333.
14.Anwar, MY et al. (2016) Time series analysis of malaria in Afghanistan: using ARIMA models to predict future trends in incidence. Malaria Journal 15, 566.
15.Specht, DF (1991) A general regression neural network. IEEE Transactions on Neural Networks 2, 568–576.
16.Zhang, G et al. (2013) Application of a hybrid model for predicting the incidence of tuberculosis in Hubei, China. PLoS ONE 8, e80969.
17.Fares, A (2011) Seasonality of tuberculosis. Journal of Global Infectious Diseases 3, 46–55.
18.Cao, S et al. (2013) A hybrid seasonal prediction model for tuberculosis incidence in China. BMC Medical Informatics and Decision Making 13, 56.
19.Willis, MD et al. (2012) Seasonality of tuberculosis in the United States, 1993–2008. Clinical Infectious Diseases 54, 1553–1560.
20.Moosazadeh, M et al. (2013) Seasonality and temporal variations of tuberculosis in the north of Iran. Tanaffos 12, 35–41.
21.Wei, W et al. (2016) Application of a combined model with autoregressive integrated moving average (ARIMA) and generalized regression neural network (GRNN) in forecasting hepatitis incidence in Heng County, China. PLoS ONE 11, e0156768.
22.Nnoaham, KE et al. (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. International Journal of Epidemiology 37, 113–119.
23.Song, C et al. (2017) Air pollution in China: status and spatiotemporal variations. Environmental Pollution 227, 334–347.
24.You, S et al. (2016) On the association between outdoor PM2.5 concentration and the seasonality of tuberculosis for Beijing and Hong Kong. Environmental Pollution 218, 1170–1179.
25.Smith, GS et al. (2016) Air pollution and pulmonary tuberculosis: a nested case-control study among members of a Northern California health plan. Environmental Health Perspectives 124, 761–768.
26.Lai, TC et al. (2016) Ambient air pollution and risk of tuberculosis: a cohort study. Occupational and Environmental Medicine 73, 56–61.
27.Wang, L et al. (2014) Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. The Lancet 383, 2057–2064.
28.Suthar, AB et al. (2016) Ending tuberculosis by 2030: can we do it? International Journal of Tuberculosis and Lung Disease 20, 1148.